EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MobiDB in 2027: machine-actionable access to intrinsic protein disorder knowledge

Damiano Piovesan iD, Abdeldjallil Lamara iD, Alison Mae Worth iD, Mahta Mehdiabadi iD, Sol C Begue iD, Silvio C E Tosatto iD

Nucleic Acids Research · 11.11.2026

DOI: 10.1093/nar/gkag1204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 11.11.2026. Verfasst von Damiano Piovesan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Padua, Padua35121,Italy. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ELIXIR, COST, European Union.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MobiDB (https://mobidb.org) integrates structural and functional annotations for intrinsically disordered proteins and regions across UniProtKB. The 2027 release strengthens semantic consistency, programmatic access, and reproducible reuse. A refined controlled vocabulary groups features in a hierarchical way and distinguishes evidence classes and types annotation sources as providers, methods, or aggregation rules. A new versioned REST API, along with a developed MCP server, enables scripts, workflows, and tool-using artificial intelligence systems to retrieve and combine evidence-bearing records through documented operations. The redesigned website applies the same vocabulary to protein entries, documentation, and cross-proteome statistics. Additional developments include standardized Nextflow production workflows, updated RING Protein Data Bank interaction processing, integration of Motif Map of the Proteome and Linear Motif mediated Protein–Protein Interaction Database annotations, and a release-aware catalogue of static datasets for large-scale analysis. Following the recent increase in reference proteomes in UniProtKB, MobiDB now provides a more representative estimate of long-disorder with a median residue coverage of 12.3% in eukaryotes, 1.9% in archaea, 1.7% in bacteria, and 3.4% in viruses; and protein prevalence of 48.7%, 11.9%, 11.2%, and 25.0%, respectively. Together, these developments make disorder knowledge easier to discover, relate to function, and reuse with explicit provenance.

Autor:innen und Institutionen

  • Department of Biomedical Sciences, University of Padua, Padua35121,Italy.
  • Department of Biomedical Sciences, University of Padua, Padua35121, Italy.

ORCID-Profile: Damiano Piovesan, Abdeldjallil Lamara, Alison Mae Worth, Mahta Mehdiabadi, Sol C Begue, Silvio C E Tosatto

Förderung

  • ELIXIR
  • COST
  • European Union
  • NextGenerationEU

Zitieren

APA

Piovesan, D., Lamara, A., Worth, A. M., Mehdiabadi, M., Begue, S. C., & Tosatto, S. C. E. (2026). MobiDB in 2027: machine-actionable access to intrinsic protein disorder knowledge. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag1204

Vancouver

Piovesan D, Lamara A, Worth AM, Mehdiabadi M, Begue SC, Tosatto SCE. MobiDB in 2027: machine-actionable access to intrinsic protein disorder knowledge. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag1204

BibTeX
@article{Piovesan2026,
  author = {Piovesan, Damiano and Lamara, Abdeldjallil and Worth, Alison Mae and Mehdiabadi, Mahta and Begue, Sol C and Tosatto, Silvio C E},
  title = {MobiDB in 2027: machine-actionable access to intrinsic protein disorder knowledge},
  journal = {Nucleic Acids Research},
  year = {2026},
  doi = {10.1093/nar/gkag1204}
}
Kostenlos starten →